A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is a randomized, open-label, parallel-controlled study to compare the PK, safety, and immunogenicity of CM326 administered via different delivery devices in healthy subjects.
Epistemonikos ID: 0df68dfcdf7ac8eb3470c8fc52406c1368252a8f
First added on: May 01, 2026